Vuno Inc. (KOSDAQ:338220)

Market Cap	276.21B
Revenue (ttm)	25.87B
Net Income (ttm)	-13.02B
Shares Out	14.00M
EPS (ttm)	-943.00
PE Ratio	n/a
Forward PE	920.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,034
Average Volume	72,999
Open	19,930
Previous Close	19,730
Day's Range	19,820 - 20,700
52-Week Range	15,490 - 39,700
Beta	1.52
RSI	55.26
Earnings Date	May 9, 2025

About Vuno Inc.

Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalit...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 338220

Financial Performance

In 2024, Vuno Inc.'s revenue was 25.87 billion, an increase of 94.86% compared to the previous year's 13.28 billion. Losses were -13.02 billion, -16.69% less than in 2023.